Prostate Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Prostate Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating androgen deprivation combined with docetaxel and enzalutamide for metastatic prostate cancer; resul…
-
CLINICAL_TRIALS trial_result · 2023-04-10Clinical Trial Update: 68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer [Phase 2, Phase 3]
Phase 2/Phase 3 clinical trial investigating 68Ga-RM2 PET/MRI in biochemically recurrent prostate cancer has completed with results posted.
-
CLINICAL_TRIALS research · 2023-03-07Clinical Trial Update: Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer [Phase 1, Phase 2]
Clinical trial update for Hypo-Combi Trial evaluating hypofractionated EBRT plus HDR-BT boost in prostate cancer, currently phase 1/2 and no…
-
CLINICAL_TRIALS trial_result · 2023-02-24Clinical Trial Update: Ga-68-PSMA-11 in Men With Prostate Cancer [Phase 3]
Phase 3 trial update for Ga-68-PSMA-11 in prostate cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2023-01-12Clinical Trial Update: Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203) [NA]
A completed pilot trial evaluating stereotactic body radiotherapy with integrated boost for localized prostate cancer; results posted in 202…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-12-16Clinical Trial Update: Diet and Exercise Program to Promote Weight Loss and Improve Health in Men With Low- or Low-Intermediate-Risk Prostate Cancer [NA]
A clinical trial evaluating a diet and exercise program for weight loss and health improvement in men with low- to low-intermediate-risk pro…
-
CLINICAL_TRIALS trial_result · 2022-09-22Clinical Trial Update: Evaluation of PSMA Antagonist Produced by Two Different Methods [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating a PSMA antagonist produced by two different methods for metastatic prostate adenocarcinoma; trial comple…
-
CLINICAL_TRIALS trial_result · 2022-08-10Clinical Trial Update: Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer [Phase 2]
A Phase 2 trial evaluating apalutamide with a gonadotropin-releasing hormone analogue, with or without abiraterone acetate, in men with vari…
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 clinical trial update for sEphB4-HSA in metastatic castration-resistant prostate cancer; status not clearly specified and results po…
-
CLINICAL_TRIALS withdrawal · 2022-03-29Clinical Trial Update: Trial of NanoPac Focal Therapy for Prostate Cancer [Phase 2]
A Phase 2 trial of NanoPac focal therapy for prostate cancer was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-04Clinical Trial Update: 68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery [Phase 2, Phase 3]
A phase 2/3 clinical trial investigating 68Ga-PSMA-11 PET/MRI for detecting tumors in intermediate- to high-risk prostate cancer patients un…
-
CLINICAL_TRIALS trial_result · 2022-01-13Clinical Trial Update: 68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment [Phase 2, Phase 3]
Phase 2/3 trial evaluating 68Ga-PSMA PET/CT for detecting prostate cancer recurrence in patients with elevated PSA after initial treatment h…
-
CLINICAL_TRIALS trial_result · 2021-09-30Clinical Trial Update: 68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer [Phase 2]
Phase 2 trial update evaluating 68Ga-PSMA-11 PET/CT for influencing treatment decisions in biochemically recurrent and metastatic prostate c…
-
CLINICAL_TRIALS research · 2021-08-10Clinical Trial Update: Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing Observation [NA]
Clinical trial update on cholecalciferol (vitamin D3) supplementation in patients with localized prostate cancer under observation; trial co…
-
CLINICAL_TRIALS trial_result · 2021-07-30Clinical Trial Update: Hypofractionated Image-Guided Radiotherapy For Prostate Cancer: The HEIGHT Trial [NA]
A completed clinical trial (HEIGHT) evaluating hypofractionated image-guided radiotherapy for prostate cancer with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-07-02Clinical Trial Update: Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy [Phase 3]
Phase 3 trial evaluating Gallium-68 labeled PSMA-11 PET/CT for detecting recurrent prostate cancer after initial therapy has completed.
-
CLINICAL_TRIALS trial_result · 2021-06-16Clinical Trial Update: MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate Cancer [NA]
Clinical trial update for MRI-guided lattice extreme ablative dose radiotherapy in prostate cancer, with completed status and results posted…
-
CLINICAL_TRIALS trial_result · 2021-06-14Clinical Trial Update: Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer [Phase 3]
Phase 3 clinical trial update evaluating 18F-DCFPyL PET/CT imaging for suspected recurrence of prostate cancer has completed with results po…
-
CLINICAL_TRIALS trial_result · 2021-03-29Clinical Trial Update: Apalutamide in Treating Patients With Prostate Cancer Who Are in Active Surveillance [Phase 2]
Phase 2 trial update on apalutamide for prostate cancer patients under active surveillance has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-08Clinical Trial Update: Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI [Phase 3]
Phase 3 trial update evaluating hybrid C11-Choline PET/MR and mpMRI for staging prostate cancer has completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-01-13Clinical Trial Update: Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy [Phase 2]
This Phase 2 clinical trial update investigates genetic and molecular factors associated with response to enzalutamide in prostate cancer, i…
-
CLINICAL_TRIALS trial_result · 2021-01-06Clinical Trial Update: Utilising CTC Counts to Optimize Systemic Therapy of Metastatic Prostate Cancer [Phase 3]
Phase 3 trial on using circulating tumor cell counts to optimize systemic therapy for metastatic prostate cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2020-11-24Clinical Trial Update: Two StereoTactic Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer [Phase 1, Phase 2]
Clinical trial update for stereoTactic Ablative Adaptive Radiotherapy treatments in localized prostate cancer (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2020-09-21Clinical Trial Update: Olaparib Before Surgery in Treating Participants With Localized Prostate Cancer [Phase 2]
Phase 2 trial evaluating olaparib before surgery in localized prostate cancer; study terminated with posted results in 2020.
-
CLINICAL_TRIALS trial_result · 2020-01-31Clinical Trial Update: Pilot Study of 18F-DCFPyL PET/CT in the Evaluation of Men With an Elevated PSA Following Radical Prostatectomy [NA]
Pilot study evaluating 18F-DCFPyL PET/CT for assessing men with elevated PSA after radical prostatectomy; study status completed with result…